ATE516805T1 - Medikament zur behandlung von endometriose - Google Patents

Medikament zur behandlung von endometriose

Info

Publication number
ATE516805T1
ATE516805T1 AT08751001T AT08751001T ATE516805T1 AT E516805 T1 ATE516805 T1 AT E516805T1 AT 08751001 T AT08751001 T AT 08751001T AT 08751001 T AT08751001 T AT 08751001T AT E516805 T1 ATE516805 T1 AT E516805T1
Authority
AT
Austria
Prior art keywords
medicine
treating endometriosis
endometriosis
treating
Prior art date
Application number
AT08751001T
Other languages
English (en)
Inventor
Antonio Pellicer-Martinez
Carlos Simon-Valles
Edurne Novella-Maestre
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07250429A external-priority patent/EP1952813A1/de
Priority claimed from GB0712626A external-priority patent/GB2450533A/en
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE516805T1 publication Critical patent/ATE516805T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08751001T 2007-02-01 2008-02-01 Medikament zur behandlung von endometriose ATE516805T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07250429A EP1952813A1 (de) 2007-02-01 2007-02-01 Medikament zur Behandlung von Endometriose
US94716507P 2007-06-29 2007-06-29
GB0712626A GB2450533A (en) 2007-06-29 2007-06-29 Treatment and prevention of endometriosis using dopamine agonists.
PCT/IB2008/001273 WO2008093247A2 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
ATE516805T1 true ATE516805T1 (de) 2011-08-15

Family

ID=39674574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08751001T ATE516805T1 (de) 2007-02-01 2008-02-01 Medikament zur behandlung von endometriose

Country Status (21)

Country Link
US (2) US8927568B2 (de)
EP (1) EP2109449B1 (de)
JP (1) JP5211073B2 (de)
AR (1) AR065139A1 (de)
AT (1) ATE516805T1 (de)
AU (1) AU2008211633B2 (de)
BR (1) BRPI0806944A2 (de)
CA (1) CA2676910C (de)
DK (1) DK2109449T3 (de)
HK (1) HK1134911A1 (de)
IL (1) IL200032A (de)
JO (1) JO2730B1 (de)
MX (1) MX2009008191A (de)
NZ (1) NZ578569A (de)
PL (1) PL2109449T3 (de)
PT (1) PT2109449E (de)
RU (1) RU2423146C2 (de)
SA (1) SA08290041B1 (de)
SI (1) SI2109449T1 (de)
TW (1) TWI411436B (de)
WO (1) WO2008093247A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2765997A1 (en) * 2009-06-26 2010-12-29 Ferring B.V. Treatment of endometriosis
EP3017809A1 (de) 2014-11-07 2016-05-11 Ferring B.V. Arzneimittelvorrichtung mit Quinagolid
US20200315996A1 (en) * 2016-06-02 2020-10-08 Board Of Trustees, Southern Illinois University Treatment of Endometriosis and Niclosamide Derivatives
WO2018221562A1 (ja) * 2017-05-30 2018-12-06 有限会社イムノ 活性化t細胞からのil-8産生を抑制するための組成物
RU2732251C1 (ru) * 2019-11-29 2020-09-14 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ лечения наружного генитального эндометриоза
WO2023031218A1 (en) * 2021-08-31 2023-03-09 Ferring B.V. Diagnosis and treatment of ectopic endometriosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208417A3 (de) 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Verwendung von 1-(8alpha-Ergolinyl)-3,3-diethylureaderivaten zur Behandlung von Endometritis
WO1993003752A1 (en) * 1991-08-19 1993-03-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Decapeptide having dopamine stimulating activity
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
RU2273481C2 (ru) * 2004-05-27 2006-04-10 Варвара Анатольевна Волкова Способ повышения эффективности лечения бесплодия, вызванного малыми формами внешнего генитального эндометриоза
ATE475420T1 (de) * 2005-04-29 2010-08-15 Ferring Int Ct Sa Behandlung oder vorbeugung des ovariellen überstimulationssyndroms (ohss) mit einem dopaminagonisten
CA2765997A1 (en) 2009-06-26 2010-12-29 Ferring B.V. Treatment of endometriosis

Also Published As

Publication number Publication date
HK1134911A1 (en) 2010-05-20
SA08290041B1 (ar) 2012-06-05
US20150073010A1 (en) 2015-03-12
IL200032A0 (en) 2010-04-15
PT2109449E (pt) 2011-11-02
NZ578569A (en) 2011-08-26
CA2676910A1 (en) 2008-08-07
TWI411436B (zh) 2013-10-11
CA2676910C (en) 2012-01-03
JP2010517992A (ja) 2010-05-27
WO2008093247A3 (en) 2008-12-04
RU2009129252A (ru) 2011-03-10
SI2109449T1 (sl) 2011-11-30
TW200845989A (en) 2008-12-01
WO2008093247A2 (en) 2008-08-07
AU2008211633A1 (en) 2008-08-07
EP2109449A2 (de) 2009-10-21
AR065139A1 (es) 2009-05-20
US20100113499A1 (en) 2010-05-06
JO2730B1 (en) 2013-09-15
IL200032A (en) 2015-06-30
JP5211073B2 (ja) 2013-06-12
US9023862B2 (en) 2015-05-05
PL2109449T3 (pl) 2011-12-30
BRPI0806944A2 (pt) 2014-05-06
DK2109449T3 (da) 2011-09-12
EP2109449B1 (de) 2011-07-20
US8927568B2 (en) 2015-01-06
MX2009008191A (es) 2009-08-12
AU2008211633B2 (en) 2011-04-21
RU2423146C2 (ru) 2011-07-10

Similar Documents

Publication Publication Date Title
CY2016053I1 (el) Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας
SE0702104L (sv) Förfarande för behandling av avfall
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DK2405869T3 (da) Fedmebehandling
ATE435271T1 (de) Zusammensetzungen zur wäschebehandlung
ATE430187T1 (de) Zusammensetzungen zur wäschebehandlung
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
BRPI0916125A2 (pt) "dispositivo de tratamento"
BRPI0910854A2 (pt) métodos de tratamento
BRPI0914294A2 (pt) aparelho de tratamento de cápsulas
ATE532507T1 (de) Neramexane zur behandlung von subakuten tinnitus
ATE445586T1 (de) Terphenylderivate zur alzheimerbehandlung
DE602008003597D1 (de) Vorrichtung zur Darstellung von Optotypen
DK2330887T3 (da) Behandlingsindretning
ATE525904T1 (de) Behandlung von bananen
DK2173831T3 (da) Brøndbehandling
DK2321359T3 (da) Fremgangsmåde til behandling af naturlige gummiprodukter
FI20061043A0 (fi) Selän hoitolaite
BRPI0822129A2 (pt) Inibidores de aldh-2c no tratamento de vício.
DK2131841T3 (da) Fremgangsmåder til behandling af akut smerte
ATE516805T1 (de) Medikament zur behandlung von endometriose
ATE537178T1 (de) Neue klasse von spiro-piperidinen zur behandlung neurodegenerativer krankheiten
AT509344A5 (de) Vorrichtung zum gesteuerten auslösen von lawinen
ATE522596T1 (de) Wäschebehandlungsmittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2109449

Country of ref document: EP